CE Mark Reduces Recipient Age for Bioprosthetic Heart Valve

Published date : 25 September 2012
Article date : 25 September 2012

Massdevice reports that the Sorin Group has won CE Mark approval to extend the use of its Perceval bioprosthetic heart valve and introduce a new suite of implantation accessories.

 
The Perceval valve originally won a CE Mark last year but was limited to use in patients aged 75 or older. The new indication now lowers the age to 65 for patients with aortic valve stenosis or steno-insufficiency.
 
Source: Massdevice.com, 18 September 2012
 
Read the full article here.
Back to Listings

Share |

Find a Device

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.